---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-211066"
form_type: "8-K"
ticker: "FBRX"
cik: "0001419041"
company_name: "Forte Biosciences, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:46:32.424198+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Forte Biosciences implements 1-for-25 reverse stock split effective August 28, 2024

## Summary
- Reverse stock split at 1-for-25 ratio effective 8:00 a.m. ET on August 28, 2024.
- No fractional shares issued; cash paid for fractional shares based on Aug 27 closing price.
- CUSIP changed to 34962G 208; trading symbol FBRX unchanged on Nasdaq.
- Proportionate adjustments made to equity incentive plans and outstanding awards.

## SEC filing metadata
- accession: 0001193125-24-211066
- form_type: 8-K
- ticker: FBRX
- cik: 0001419041
- company_name: Forte Biosciences, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419041/000119312524211066/0001193125-24-211066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419041/000119312524211066/d838050d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-211066
- JSON: https://secwatch.observer/filing/0001193125-24-211066.json
- Plain text: https://secwatch.observer/filing/0001193125-24-211066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.